The pharmacology of recurrent inhibition in the supraoptic neurosecretory system.
D000109:Acetylcholine / Q000494:pharmacology; D000470:Alkaloids / Q000494:pharmacology; D000613:Aminobutyrates / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002415:Cats; D005998:Glycine / Q000494:pharmacology; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects*; D007031:Hypothalamus / Q000187:drug effects*; D007546:Isoquinolines / Q000494:pharmacology; D018377:Neurotransmitter Agents / Q000494:pharmacology / Q000502:physiology*; D009638:Norepinephrine / Q000494:pharmacology; D010852:Picrotoxin / Q000494:pharmacology; D013331:Strychnine / Q000494:pharmacology; D014667:Vasopressins / Q000494:pharmacology
D000109:Acetylcholine; D000470:Alkaloids; D000613:Aminobutyrates; D001285:Atropine; D005998:Glycine; D007546:Isoquinolines; D018377:Neurotransmitter Agents; D009638:Norepinephrine; D010852:Picrotoxin; D013331:Strychnine; D014667:Vasopressins